GJ

Gagan Jot Singh

Active Director Director DIN 05271026
DIN 05271026 First appointment May 2012 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 1 historical roles
Total affiliations 5 Since May 2012
Shareholding value •••• Premium profile

About Gagan Jot Singh

Data last updated:

Gagan Jot Singh is a Director at Avanscure Lifesciences Private Limited (since 2012), Director at Elevatoz Loyalty Private Limited (since 2018) and Director at Avansdose Pharmatech Private Limited (since 2017), and holds 1 more current directorship. The companies operate in Pharma, Business Services and Healthcare. The 3 current companies with reported revenue have a combined latest revenue of ₹79.99 Cr; the largest is Avanscure Lifesciences Private Limited at ₹38.07 Cr (FY 2025). Earlier, Gagan Jot Singh was a Designated Partner at Cliniv Health Tech Llp (2020–2021).

DIN 05271026
Primary Designation Director
Industry Pharma
First Appointment 07 May 2012
Oldest Company Age 14 yrs
Largest company Avanscure Lifesciences Private Limited · ₹38.07 Cr (FY 2025)
Combined revenue ₹79.99 Cr across 3 companies

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 May 20122012₹38.07 Cr (FY 2025)Active
Elevatoz Loyalty Private Limited U74999KA2018PTC112520
Director26 Apr 20182018₹29.21 Cr (FY 2025)Active
Avansdose Pharmatech Private Limited U74999TG2017PTC115497
Director27 Feb 20172017₹12.71 Cr (FY 2025)Active
Atomikon Sciences Private Limited U15545KA2019PTC124380
Director16 May 20192019Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner19 Jul 20202020Converted And Dissolved

Explore Director's current and past company associations Uncover their professional journey today!

Directorship timeline

Open interactive timeline →
Atomikon Sciences Private Limited
Avanscure Lifesciences Private Limited
Elevatoz Loyalty Private Limited
Avansdose Pharmatech Private Limited
Premium access

Shareholding and investment profile for Gagan Jot Singh

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gagan Jot Singh

Gagan Jot Singh currently holds 4 directorships: Avanscure Lifesciences Private Limited (Director, since 07 May 2012, revenue ₹38.07 Cr (FY 2025)); Elevatoz Loyalty Private Limited (Director, since 26 Apr 2018, revenue ₹29.21 Cr (FY 2025)); Avansdose Pharmatech Private Limited (Director, since 27 Feb 2017, revenue ₹12.71 Cr (FY 2025)); Atomikon Sciences Private Limited (Director, since 16 May 2019).

Gagan Jot Singh was first appointed on 07 May 2012 as Director at Avanscure Lifesciences Private Limited. The most recent appointment on record is 19 Jul 2020 at Cliniv Health Tech Llp.

The 3 current companies of Gagan Jot Singh that report revenue have a combined latest revenue of ₹79.99 Cr: Avanscure Lifesciences Private Limited ₹38.07 Cr (FY 2025); Elevatoz Loyalty Private Limited ₹29.21 Cr (FY 2025); Avansdose Pharmatech Private Limited ₹12.71 Cr (FY 2025).

Gagan Jot Singh held 1 earlier board appointment: Cliniv Health Tech Llp (Designated Partner, 19 Jul 2020 to 01 Jul 2021).

The current boards of Gagan Jot Singh's companies include Madan Pal Singh (Avanscure Lifesciences Private Limited), Sudeep Kumar (Elevatoz Loyalty Private Limited), Sushma Prasanna (Elevatoz Loyalty Private Limited), Ravindra Balwani (Avansdose Pharmatech Private Limited), Virender Kumar Dabas (Atomikon Sciences Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available